title: Comparison between the effects of lisinopril and losartan on the cougn reflex in anesthetized and awake rabbits.
abstract: The aim of the present study was to analyze differences in cough induction between losartan and lisinopril in both anaesthetized and awake rabbits, i.e., under conditions in which the influences of higher brain areas on the cough reflex are strongly reduced or abolished. Losartan (500 μg/kg), lisinopril (100 μg/kg) and NaCl 0.9% saline solution (vehicle) were administered by intravenous injections. Animals were randomly assigned to the different experimental treatments. The cough reflex was induced by chemical (citric acid) and/or mechanical stimulation of the tracheobronchial tree. In anaesthetized rabbits, losartan and lisinopril caused similar hypotensive effects. Lisinopril, but not losartan, increased the cough response induced by both mechanical and chemical stimulation due to increases in the cough number, i.e. the number of coughs induced by each stimulation challenge. In awake animals, only lisinopril significantly increased the cough number. The results support the notion that cough potentiation induced by losartan, and possibly other sartans, is lower than that induced by most angiotensin-converting enzyme inhibitors despite the reduction or complete absence of higher brain functions. In this connection, the comparison between present results and our previous findings on ramipril and zofenopril shows that losartan and zofenopril display similar cough-inducing potency, much lower than that of lisinopril and ramipril.
authors.affiliation: Department of Physiological Sciences, Universita degli Studi di Firenze, Firenze, Italy.
authors.forename: D
authors.initials: D
authors.lastname: Mutolo
authors.forename: E
authors.initials: E
authors.lastname: Cinelli
authors.forename: F
authors.initials: F
authors.lastname: Bongianni
authors.forename: S
authors.initials: S
authors.lastname: Evangelista
authors.forename: T
authors.initials: T
authors.lastname: Pantaleo
mesh_terms: D000280:Administration, Inhalation; D061605:Administration, Intravenous; D000758:Anesthesia; D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage / Q000009:adverse effects*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D000818:Animals; D019343:Citric Acid / Q000008:administration & dosage; D003371:Cough / Q000139:chemically induced*; D017706:Lisinopril / Q000008:administration & dosage / Q000009:adverse effects*; D019808:Losartan / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D010812:Physical Stimulation; D011817:Rabbits; D012018:Reflex / Q000187:drug effects
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D019343:Citric Acid; D017706:Lisinopril; D019808:Losartan